Symposium:
108. HIV and STDs
Saturday, October 23, 2010: 10:30 AM-12:00 PM
301-305

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the epidemiology and risk factors for sexually transmitted hepatitis C
  • discuss several examples of interactions between HIV disease and sexually transmitted infections
  • describe recent changes in STD epidemiology, including issues pertaining to special populations

Target Audience: Pharmacists, Infectious Disease Physicians, HIV Clinicians, Clinicians

Topical Category: H. HIV/AIDS and other retroviruses

Tracks: HIV

CME Credits: CME Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE Maximum of 1.5 hours of Pharmacy CE credit possible

ACPE Number: 0245-9999-10-039-L02-P (Knowledge)

Moderators:  Connie Celum, MD, FIDSA, University of Washington and Joel Gallant, MD, MPH, FIDSA, John Hopkins University School of Medicine

Disclosures:

C. Celum, Yes
Glaxo Smith Kline: Investigator, Research grant

J. Gallant, Yes
Abbott Laboratories: Consultant, Consulting fee
Bristol-Myers Squibb: Scientific Advisor, Consulting fee
Gilead Sciences: Grant Investigator and Scientific Advisor, Consulting fee and Research support
Merck & Company: Scientific Advisor, Consulting fee
Sangamo Biosciences: Scientific Advisor, Consulting fee
Tibotec: Scientific Advisor, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 21 with the exception of research findings presented at IDSA press conferences.

 
 
   
 

Copyright IDSA 2009 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org